Coherus Oncology, Inc. (CHRS) Stock Price History
Historical prices from 2014 to 2026
Loading 10-year price history...
CHRS Historical Performance
Short-Term Returns
CHRS Stock Price Trajectory (2014–2026)
As of May 8, 2026, Coherus Oncology, Inc. (CHRS) trades at $1.76, representing a +86.0% return over the past year. The stock has delivered a -87.7% total return over five years (-34.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $38.10 on July 22, 2015. From this peak, CHRS has corrected -95.4%, currently trading 15% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers PRGO (-55.6% 1Y), AMRX (+90.0% 1Y), and HCM (-8.8% 1Y), CHRS has underperformed the peer group average. Compare CHRS vs PRGO →
CHRS Historical Price Data (2025–2026)
Showing 30 of 2,892 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 1.73 | 1.76 | 1.71 | 1.76 | 903K | +0.57% |
| 2026-05-06 | 1.83 | 1.87 | 1.75 | 1.75 | 1.28M | -2.23% |
| 2026-05-05 | 1.74 | 1.80 | 1.74 | 1.79 | 803K | +3.47% |
| 2026-05-04 | 1.81 | 1.82 | 1.73 | 1.73 | 715K | -3.89% |
| 2026-05-01 | 1.75 | 1.80 | 1.73 | 1.80 | 516K | +1.41% |
| 2026-04-30 | 1.75 | 1.83 | 1.74 | 1.77 | 437K | +2.01% |
| 2026-04-29 | 1.75 | 1.75 | 1.70 | 1.74 | 656K | -1.69% |
| 2026-04-28 | 1.79 | 1.85 | 1.75 | 1.77 | 624K | -3.80% |
| 2026-04-27 | 1.75 | 1.89 | 1.74 | 1.84 | 1.03M | +5.14% |
| 2026-04-24 | 1.76 | 1.76 | 1.72 | 1.75 | 906K | -0.57% |
| 2026-04-23 | 1.79 | 1.81 | 1.69 | 1.76 | 1.31M | -2.22% |
| 2026-04-22 | 1.85 | 1.85 | 1.77 | 1.80 | 761K | -1.10% |
| 2026-04-21 | 1.98 | 1.99 | 1.81 | 1.82 | 1.92M | -8.54% |
| 2026-04-20 | 1.96 | 2.02 | 1.93 | 1.99 | 748K | +0.51% |
| 2026-04-17 | 1.94 | 1.99 | 1.88 | 1.98 | 1.75M | +4.21% |
| 2026-04-16 | 1.87 | 1.96 | 1.85 | 1.90 | 1.64M | +1.06% |
| 2026-04-15 | 1.78 | 1.88 | 1.76 | 1.88 | 1.07M | +4.44% |
| 2026-04-14 | 1.72 | 1.82 | 1.71 | 1.80 | 1.03M | +5.26% |
| 2026-04-13 | 1.67 | 1.71 | 1.62 | 1.71 | 910K | +1.79% |
| 2026-04-10 | 1.64 | 1.69 | 1.64 | 1.68 | 552K | +1.82% |
| 2026-04-09 | 1.69 | 1.70 | 1.61 | 1.65 | 990K | -2.94% |
| 2026-04-08 | 1.75 | 1.76 | 1.67 | 1.70 | 815K | +1.80% |
| 2026-04-07 | 1.67 | 1.71 | 1.59 | 1.67 | 722K | 0.00% |
| 2026-04-06 | 1.74 | 1.78 | 1.67 | 1.67 | 616K | -3.47% |
| 2026-04-02 | 1.69 | 1.75 | 1.68 | 1.73 | 535K | -0.57% |
| 2026-04-01 | 1.72 | 1.79 | 1.70 | 1.74 | 789K | +2.96% |
| 2026-03-31 | 1.64 | 1.73 | 1.63 | 1.69 | 862K | +5.62% |
| 2026-03-30 | 1.66 | 1.66 | 1.58 | 1.60 | 791K | -1.84% |
| 2026-03-27 | 1.65 | 1.68 | 1.61 | 1.63 | 684K | -1.81% |
| 2026-03-26 | 1.74 | 1.78 | 1.66 | 1.66 | 687K | -6.21% |
See CHRS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CHRS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CHRS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCHRS — Frequently Asked Questions
Quick answers to the most common questions about buying CHRS stock.
How has CHRS stock performed recently?
CHRS returned +86.0% over the past year, beating its 5-year annualized CAGR of -34.2%. The stock trades above its 200-day moving average, confirming the uptrend.
What is CHRS's all-time high price?
Coherus Oncology, Inc. reached $38.10 on 2015-07-22. The 52-week high is $2.62. Current 1-year return of +86.0% places the stock closer to historical peaks.
Where can I download CHRS historical price data?
This page provides CHRS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.